The relationships of plasma adiponectin with a favorable lipid profile, decreased inflammation, and less ectopic fat accumulation depend on adiposity - PubMed (original) (raw)
. 2006 Oct;52(10):1934-42.
doi: 10.1373/clinchem.2006.067397. Epub 2006 Aug 17.
Affiliations
- PMID: 16916991
- DOI: 10.1373/clinchem.2006.067397
The relationships of plasma adiponectin with a favorable lipid profile, decreased inflammation, and less ectopic fat accumulation depend on adiposity
Konstantinos Kantartzis et al. Clin Chem. 2006 Oct.
Abstract
Background: The metabolic effects of adiponectin, including insulin sensitivity, seem to become stronger with increasing adiposity. Adiposity may also affect the relationship of adiponectin concentrations with serum lipid profile; markers of inflammation, atherosclerosis, and endothelial function; and ectopic fat accumulation.
Methods: We measured plasma adiponectin concentrations, serum lipids, and serum markers of inflammation, atherosclerosis, and endothelial function in 242 Caucasians without type 2 diabetes. We also measured visceral adipose tissue with magnetic resonance tomography and liver and intramyocellular fat with (1)H magnetic resonance spectroscopy.
Results: We divided the study participants into 2 groups: lean [mean (SE) total body fat, 26% (0.6%); n = 119] and obese [36% (0.6%); n = 123]. In the obese group, plasma adiponectin concentrations showed a strong positive association with concentrations of HDL cholesterol (P <0.0001) and negative associations with LDL cholesterol, triglycerides, high-sensitivity C-reactive protein, interleukin 6, apolipoprotein B(100), soluble E-selectin, soluble vascular cellular adhesion molecule 1, plasminogen activator inhibitor 1, leukocyte count, and liver and intramyocellular fat (all P <0.03). In the lean group, adiponectin showed a less strong association with HDL cholesterol (P = 0.005) and liver fat (P = 0.03) and no significant associations with the other variables (all P >0.10). High visceral adipose tissue was a strong predictor of low adiponectin concentrations, particularly in the obese group, and attenuated many of the significant relationships.
Conclusions: High adiponectin plasma concentrations are associated with favorable lipid profiles, decreased subclinical inflammation, decreased markers of atherosclerosis and endothelial function, and low ectopic fat accumulation, particularly in obese persons. Adiponectin may also have a concentration-related effect on the relationship between visceral adipose tissue and these metabolic characteristics, especially in obese persons.
Similar articles
- Predictors of ectopic fat accumulation in liver and pancreas in obese men and women.
Rossi AP, Fantin F, Zamboni GA, Mazzali G, Rinaldi CA, Del Giglio M, Di Francesco V, Barillari M, Pozzi Mucelli R, Zamboni M. Rossi AP, et al. Obesity (Silver Spring). 2011 Sep;19(9):1747-54. doi: 10.1038/oby.2011.114. Epub 2011 May 19. Obesity (Silver Spring). 2011. PMID: 21593811 - Visceral Adiposity Measurements, Metabolic and Inflammatory Profi le in Obese Patients with and Without Type 2 Diabetes Mellitus: A Crosssectional Analysis.
Wanderley Rocha DR, Jorge AR, Braulio VB, Arbex AK, Marcadenti A. Wanderley Rocha DR, et al. Curr Diabetes Rev. 2017;13(1):11-18. doi: 10.2174/1573399812666151015115924. Curr Diabetes Rev. 2017. PMID: 26467189 - Increased fat accumulation in liver may link insulin resistance with subcutaneous abdominal adipocyte enlargement, visceral adiposity, and hypoadiponectinemia in obese individuals.
Koska J, Stefan N, Permana PA, Weyer C, Sonoda M, Bogardus C, Smith SR, Joanisse DR, Funahashi T, Krakoff J, Bunt JC. Koska J, et al. Am J Clin Nutr. 2008 Feb;87(2):295-302. doi: 10.1093/ajcn/87.2.295. Am J Clin Nutr. 2008. PMID: 18258617 - Establishment of a concept of visceral fat syndrome and discovery of adiponectin.
Matsuzawa Y. Matsuzawa Y. Proc Jpn Acad Ser B Phys Biol Sci. 2010;86(2):131-41. doi: 10.2183/pjab.86.131. Proc Jpn Acad Ser B Phys Biol Sci. 2010. PMID: 20154470 Free PMC article. Review. - Adiponectin: a key player in obesity related disorders.
Matsuzawa Y. Matsuzawa Y. Curr Pharm Des. 2010 Jun;16(17):1896-901. doi: 10.2174/138161210791208893. Curr Pharm Des. 2010. PMID: 20370675 Review.
Cited by
- Body fat distribution and inflammation among obese older adults with and without metabolic syndrome.
Koster A, Stenholm S, Alley DE, Kim LJ, Simonsick EM, Kanaya AM, Visser M, Houston DK, Nicklas BJ, Tylavsky FA, Satterfield S, Goodpaster BH, Ferrucci L, Harris TB; Health ABC Study. Koster A, et al. Obesity (Silver Spring). 2010 Dec;18(12):2354-61. doi: 10.1038/oby.2010.86. Epub 2010 Apr 15. Obesity (Silver Spring). 2010. PMID: 20395951 Free PMC article. - Nicotinamide mononucleotide attenuates HIF-1α activation and fibrosis in hypoxic adipose tissue via NAD+/SIRT1 axis.
Wu K, Li B, Ma Y, Tu T, Lin Q, Zhu J, Zhou Y, Liu N, Liu Q. Wu K, et al. Front Endocrinol (Lausanne). 2023 Jan 26;14:1099134. doi: 10.3389/fendo.2023.1099134. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 36777361 Free PMC article. - Adiponectin, Obesity, and Cancer: Clash of the Bigwigs in Health and Disease.
Parida S, Siddharth S, Sharma D. Parida S, et al. Int J Mol Sci. 2019 May 22;20(10):2519. doi: 10.3390/ijms20102519. Int J Mol Sci. 2019. PMID: 31121868 Free PMC article. Review. - Gender differences in insulin resistance, body composition, and energy balance.
Geer EB, Shen W. Geer EB, et al. Gend Med. 2009;6 Suppl 1(Suppl 1):60-75. doi: 10.1016/j.genm.2009.02.002. Gend Med. 2009. PMID: 19318219 Free PMC article. Review. - Effect of energy restriction and physical exercise intervention on phenotypic flexibility as examined by transcriptomics analyses of mRNA from adipose tissue and whole body magnetic resonance imaging.
Lee S, Norheim F, Langleite TM, Noreng HJ, Storås TH, Afman LA, Frost G, Bell JD, Thomas EL, Kolnes KJ, Tangen DS, Stadheim HK, Gilfillan GD, Gulseth HL, Birkeland KI, Jensen J, Drevon CA, Holen T; NutriTech Consortium. Lee S, et al. Physiol Rep. 2016 Nov;4(21):e13019. doi: 10.14814/phy2.13019. Physiol Rep. 2016. PMID: 27821717 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials